Xianbin Kong

569 total citations
24 papers, 405 citations indexed

About

Xianbin Kong is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Xianbin Kong has authored 24 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in Xianbin Kong's work include Virus-based gene therapy research (5 papers), Cancer Research and Treatments (4 papers) and Nerve injury and regeneration (4 papers). Xianbin Kong is often cited by papers focused on Virus-based gene therapy research (5 papers), Cancer Research and Treatments (4 papers) and Nerve injury and regeneration (4 papers). Xianbin Kong collaborates with scholars based in China. Xianbin Kong's co-authors include Yue Tu, Qingbo Li, Jin‐He Guo, Ying Li, Chuanxin Liu, Fangyuan Wang, Yuzhu Guo, Long Yang, Bo Zhang and Long Yang and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Medicine.

In The Last Decade

Xianbin Kong

24 papers receiving 401 citations

Peers

Xianbin Kong
Elnaz Faghfuri Iran
Hongtao Xiao China
Ali Anissian Iran
Xuechun Lu China
Yuanhang Ma China
Mohsen Sarikhani India
Peng Fan China
Hongbo Xu China
Shuo Yuan China
Nasser Gholijani Iran
Elnaz Faghfuri Iran
Xianbin Kong
Citations per year, relative to Xianbin Kong Xianbin Kong (= 1×) peers Elnaz Faghfuri

Countries citing papers authored by Xianbin Kong

Since Specialization
Citations

This map shows the geographic impact of Xianbin Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianbin Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianbin Kong more than expected).

Fields of papers citing papers by Xianbin Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianbin Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianbin Kong. The network helps show where Xianbin Kong may publish in the future.

Co-authorship network of co-authors of Xianbin Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xianbin Kong. A scholar is included among the top collaborators of Xianbin Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianbin Kong. Xianbin Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Ying, et al.. (2024). Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS. Biomedicine & Pharmacotherapy. 175. 116773–116773. 30 indexed citations
3.
4.
Li, Sheng, et al.. (2023). HSV: The scout and assault for digestive system tumors. Frontiers in Molecular Biosciences. 10. 1142498–1142498. 3 indexed citations
5.
Li, Qingbo, et al.. (2023). A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon. Molecular Therapy — Oncolytics. 30. 254–274. 7 indexed citations
6.
Zhang, Ze, et al.. (2023). The γδ T cells dual function and crosstalk with intestinal flora in treating colorectal cancer is a promising area of study. International Immunopharmacology. 123. 110733–110733. 3 indexed citations
7.
Wang, Fangyuan, Xianbin Kong, Qingbo Li, et al.. (2022). The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention. Biomedicine & Pharmacotherapy. 153. 113376–113376. 12 indexed citations
8.
Guo, Rui, Jin‐He Guo, Zheng Fan, et al.. (2022). Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2. Frontiers in Cellular and Infection Microbiology. 12. 931061–931061. 29 indexed citations
9.
Li, Qingbo, Patrick Kwabena Oduro, Ruiqiao Li, et al.. (2022). Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors. Frontiers in Cellular and Infection Microbiology. 12. 921534–921534. 10 indexed citations
10.
Ren, Yi, et al.. (2022). Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option. Frontiers in Immunology. 13. 961796–961796. 32 indexed citations
11.
Li, Qingbo, Yuanyuan Wang, Xiaohui Liu, et al.. (2022). The gamble between oncolytic virus therapy and IFN. Frontiers in Immunology. 13. 971674–971674. 35 indexed citations
12.
Wang, Qilong, et al.. (2022). COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. Frontiers in Immunology. 13. 978619–978619. 5 indexed citations
13.
Zhao, Chenchen, Haifeng Yan, Tong Wu, et al.. (2021). Lentinan combined with cisplatin for the treatment of non-small cell lung cancer. Medicine. 100(12). e25220–e25220. 15 indexed citations
14.
Bai, Xue, et al.. (2021). Metabolism response of grazing yak to dietary concentrate supplementation in warm season. animal. 15(3). 100175–100175. 13 indexed citations
15.
Kong, Xianbin, Jingjing Zhang, Lei Wang, et al.. (2018). A systematic investigation on animal models of cyclosporine A combined with Escherichia coli to simulate the immunosuppressive status of sepsis patients before onset. International Immunopharmacology. 62. 67–76. 8 indexed citations
16.
17.
Zhang, Sai, et al.. (2018). Saikosaponin a increases interleukin-10 expression and inhibits scar formation after sciatic nerve injury. Neural Regeneration Research. 13(9). 1650–1650. 11 indexed citations
18.
Chen, Xuyi, et al.. (2018). Exendin-4 inhibits high-altitude cerebral edema by protecting against neurobiological dysfunction. Neural Regeneration Research. 13(4). 653–653. 14 indexed citations
19.
Kong, Xianbin, R. Wang, Yunqiang Xu, et al.. (2018). Exendin-4 Plays a Protective Role in a Rat Model of Spinal Cord Injury Through SERCA2. Cellular Physiology and Biochemistry. 47(2). 617–629. 8 indexed citations
20.
Tu, Yue, et al.. (2017). Polyethylene glycol as a promising synthetic material for repair of spinal cord injury. Neural Regeneration Research. 12(6). 1003–1003. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elnaz Faghfuri Breakdown of academic impact, for papers by Hongtao Xiao Breakdown of academic impact, for papers by Ali Anissian Breakdown of academic impact, for papers by Xuechun Lu Breakdown of academic impact, for papers by Yuanhang Ma Breakdown of academic impact, for papers by Mohsen Sarikhani Breakdown of academic impact, for papers by Peng Fan Breakdown of academic impact, for papers by Hongbo Xu Breakdown of academic impact, for papers by Shuo Yuan Breakdown of academic impact, for papers by Nasser Gholijani
Rankless by CCL
2026